Quality of surgical resection for nonsmall cell lung cancer in a US metropolitan area
- PMID: 20737568
- DOI: 10.1002/cncr.25334
Quality of surgical resection for nonsmall cell lung cancer in a US metropolitan area
Abstract
Background: Curative treatment of early stage nonsmall cell lung cancer (NSCLC) requires good quality surgical resection (GQR). The degree of compliance with national recommendations for GQR is poorly defined. We sought to quantitatively define the degree of compliance in a consecutive series of NSCLC resections.
Methods: Medical records of patients who underwent curative-intent resection for NSCLC in the Memphis, TN metropolitan area from January 1, 2004 to December 31, 2007 were retrospectively reviewed (N = 746 patients). GQR criteria were obtained from the National Comprehensive Cancer Network (NCCN), the RADIANT adjuvant study of erlotinib, and the American College of Surgeons Oncology Group (ACOSOG) Z0030 study. Factors associated with or without achievement of GQR were evaluated. Categorical variables were compared using chi-square or Fisher exact test, and survival curves by the log-rank test.
Results: Twenty-three and one-half percent of patients met GQR criteria as established by RADIANT, 8.2% by NCCN, and 0.9% by ACOSOG. The most common limiting factor in achieving GQR was inadequate lymph node sampling. The only patient factor associated with GQR was race (African-Americans were more likely than Caucasians to have GQR per RADIANT and NCCN criteria [P = .022 and P = .0489, respectively]). There was no significant survival difference between GQR and non-GQR patients.
Conclusions: The vast majority of curative-intent resections did not achieve GQR standards. The greatest deficit is in surgical sampling of mediastinal (Level 2) lymph nodes, but evaluation of Level 1 lymph nodes is also suboptimal. Interventions are needed to improve current surgical practices and achieve minimum standards for accurate staging, prognostication, and eligibility for clinical trials.
© 2010 American Cancer Society.
Similar articles
-
Frequency of noncontiguous lymph node involvement in patients with resectable nonsmall cell lung carcinoma.Cancer. 1999 Oct 1;86(7):1159-64. Cancer. 1999. PMID: 10506699
-
Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections.Eur J Cardiothorac Surg. 2008 Apr;33(4):728-34. doi: 10.1016/j.ejcts.2007.12.048. Epub 2008 Feb 7. Eur J Cardiothorac Surg. 2008. PMID: 18261918
-
Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer.Cancer. 2009 Feb 15;115(4):851-8. doi: 10.1002/cncr.23985. Cancer. 2009. PMID: 19140203
-
Surgical assessment and intraoperative management of mediastinal lymph nodes in non-small cell lung cancer.Ann Thorac Surg. 2007 Sep;84(3):1059-65. doi: 10.1016/j.athoracsur.2007.04.032. Ann Thorac Surg. 2007. PMID: 17720443 Review.
-
[Recommendations for surgical treatment of nonsmall cell lung cancer].Pneumologia. 2009 Apr-Jun;58(2):135-40. Pneumologia. 2009. PMID: 19637769 Review. Romanian.
Cited by
-
Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non-Small Cell Lung Cancer.Ann Thorac Surg. 2016 Aug;102(2):448-53. doi: 10.1016/j.athoracsur.2016.03.096. Epub 2016 Jun 3. Ann Thorac Surg. 2016. PMID: 27266421 Free PMC article.
-
Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer in the US ALCHEMIST Study (Alliance A151216).JAMA Oncol. 2022 May 1;8(5):717-728. doi: 10.1001/jamaoncol.2022.0039. JAMA Oncol. 2022. PMID: 35297944 Free PMC article.
-
Two Interventions on Pathologic Nodal Staging in a Population-Based Lung Cancer Resection Cohort.Ann Thorac Surg. 2024 Mar;117(3):576-584. doi: 10.1016/j.athoracsur.2023.08.026. Epub 2023 Sep 5. Ann Thorac Surg. 2024. PMID: 37678613 Free PMC article.
-
Pathologic node-negative lung cancer: Adequacy of lymph node yield and a tool to assess the risk of occult nodal disease.Lung Cancer. 2022 Dec;174:60-66. doi: 10.1016/j.lungcan.2022.10.004. Epub 2022 Oct 20. Lung Cancer. 2022. PMID: 36334358 Free PMC article.
-
Quality gaps and comparative effectiveness in lung cancer staging and diagnosis.Chest. 2014 Feb;145(2):331-345. doi: 10.1378/chest.13-1599. Chest. 2014. PMID: 24091637 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous